1. Home
  2. APVO vs BTTR Comparison

APVO vs BTTR Comparison

Compare APVO & BTTR Stocks: Price Trends, ML Decisions, Charts, Trends, Technical Analysis and more.

  • Machine Learning Prediction
  • ML Decision
  • APVO
  • BTTR
  • Stock Information
  • Founded
  • APVO 2016
  • BTTR 1986
  • Country
  • APVO United States
  • BTTR United States
  • Employees
  • APVO N/A
  • BTTR N/A
  • Industry
  • APVO Biotechnology: Pharmaceutical Preparations
  • BTTR Beverages (Production/Distribution)
  • Sector
  • APVO Health Care
  • BTTR Consumer Staples
  • Exchange
  • APVO Nasdaq
  • BTTR Nasdaq
  • Market Cap
  • APVO 3.7M
  • BTTR 3.2M
  • IPO Year
  • APVO N/A
  • BTTR N/A
  • Fundamental
  • Price
  • APVO $0.21
  • BTTR $1.72
  • Analyst Decision
  • APVO Strong Buy
  • BTTR Strong Buy
  • Analyst Count
  • APVO 1
  • BTTR 1
  • Target Price
  • APVO $8.00
  • BTTR $10.00
  • AVG Volume (30 Days)
  • APVO 17.5M
  • BTTR 43.0K
  • Earning Date
  • APVO 11-07-2024
  • BTTR 11-12-2024
  • Dividend Yield
  • APVO N/A
  • BTTR N/A
  • EPS Growth
  • APVO N/A
  • BTTR N/A
  • EPS
  • APVO N/A
  • BTTR N/A
  • Revenue
  • APVO N/A
  • BTTR $33,519,000.00
  • Revenue This Year
  • APVO N/A
  • BTTR $428.61
  • Revenue Next Year
  • APVO N/A
  • BTTR $25.00
  • P/E Ratio
  • APVO N/A
  • BTTR N/A
  • Revenue Growth
  • APVO N/A
  • BTTR N/A
  • 52 Week Low
  • APVO $0.14
  • BTTR $1.62
  • 52 Week High
  • APVO $10.80
  • BTTR $18.00
  • Technical
  • Relative Strength Index (RSI)
  • APVO 43.68
  • BTTR 40.62
  • Support Level
  • APVO $0.24
  • BTTR $2.00
  • Resistance Level
  • APVO $0.33
  • BTTR $2.19
  • Average True Range (ATR)
  • APVO 0.04
  • BTTR 0.17
  • MACD
  • APVO -0.01
  • BTTR -0.01
  • Stochastic Oscillator
  • APVO 0.70
  • BTTR 5.06

About APVO Aptevo Therapeutics Inc.

Aptevo Therapeutics Inc is a clinical-stage, research and development biotechnology company focused on developing novel immunotherapeutic candidates for the treatment of different forms of cancer. Its clinical candidate, APVO436, and preclinical candidates, ALG.APV-527 and APVO603, were developed using ADAPTIR modular protein technology platform. The versatile and robust ADAPTIR and ADAPTIR-FLEX platforms are designed to generate monospecific, bispecific, and multi-specific antibody candidates that are capable of enhancing the human immune system against cancer cells.

About BTTR Better Choice Company Inc.

Better Choice Co Inc is a pet health and wellness portfolio company, offering consumers a wide variety of recognized premium pet products and hemp-derived CBD supplements. Its portfolio includes kibble and canned dog and cat food, freeze-dried raw dog food and treats, vegan dog food and treats, oral care products, supplements and grooming aids. Its core products sold under the Halo brand are sustainably sourced, derived from real whole meat and no rendered meat meal and include non-GMO fruits and vegetables. Its core products sold under the TruDog brand are made according to nutritional philosophy of fresh, meat-based nutrition and minimal processing.

Share on Social Networks: